Literature DB >> 519859

Sensitive in vivo assay of the phenylalanine hydroxylating system with a small intravenous dose of heptadeutero L-phenylalanine using high pressure liquid chromatography and capillary gas chromatography/mass fragmentography.

F K Trefz, T Erlenmaier, D H Hunneman, K Bartholomé, P Lutz.   

Abstract

A method is described which allows the in vivo determination of the phenylalanine hydroxylating system in atypical and classical phenylketonuria. Phenylalanine-d7 is administered i.v. (0.030 g/kg body weight) within 10 min. Tyrosine-d6 in plasma is measured from 30 to 240 min post load by using a computerized capillary gas chromatography/mass fragmentography system. In two patients with hyperphenylalaninemia, the residual activity of the phenylalanine hydroxylating system was 15.7 and 3.7% of the normal, in two phenylketonurics 1.5 and 0.3% respectively. The in vivo figures correspond well to the in vitro assay of the residual activity of the phenylalanine hydroxylase in needle liver biopsy material.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 519859     DOI: 10.1016/0009-8981(79)90264-x

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  10 in total

1.  Linkage disequilibrium between mutation and RFLP haplotype at the phenylalanine hydroxylase locus in the German population.

Authors:  U Lichter-Konecki; M Schlotter; D S Konecki; S Labeit; S L Woo; F K Trefz
Journal:  Hum Genet       Date:  1988-04       Impact factor: 4.132

2.  In vivo residual activities of the phenylalanine hydroxylating system in phenylketonuria and variants.

Authors:  F K Trefz; K Bartholomé; H Bickel; P Lutz; H Schmidt; H W Seyberth
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

3.  Phenylketonuria: past, present, future. F. P. Hudson Memorial Lecture, Leeds, 1979.

Authors:  H Bickel
Journal:  J Inherit Metab Dis       Date:  1980       Impact factor: 4.982

4.  Significance of the in vivo deuterated phenylalanine load for long-term phenylalanine tolerance and psycho-intellectual outcome in patients with PKU.

Authors:  F K Trefz; U Batzler; T König; U Michel; E Schmidt; H Schmidt; H Bickel
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

5.  Significant phenylalanine hydroxylation in vivo in patients with classical phenylketonuria.

Authors:  G N Thompson; D Halliday
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

6.  Standardized loading test with protein for the differentiation of phenylketonuria from hyperphenylalaninaemia.

Authors:  P Lutz; H Schmidt; G Frey; H Bickel
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

7.  The use of deuterated phenylalanine for the in vivo assay of phenylalanine hydroxylase activity in children.

Authors:  R Matalon; D E Matthews; K Michals; D Bier
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

8.  Compound heterozygotes in hyperphenylalaninaemia.

Authors:  K Bartholomé; K Olek; F Trefz
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

9.  Phenylalanine metabolism in isolated rat liver cells. Effects of glucagon and diabetes.

Authors:  F P Carr; C I Pogson
Journal:  Biochem J       Date:  1981-09-15       Impact factor: 3.857

10.  Phenylketonuria. The in vivo hydroxylation rate of phenylalanine into tyrosine is decreased.

Authors:  F J van Spronsen; D J Reijngoud; G P Smit; G T Nagel; F Stellaard; R Berger; H S Heymans
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.